Relay Therapeutics Inc (RLAY)
Healthcare
Biotechnology
18.80 $
-3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Relay Therapeutics Inc (RLAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69 | -75 | -89 | -50 | -66 | -75 | -58 | -73 | -55 | -62 | -45 | -51 | -213 | |
| 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | -8.8 | 1.3 | 1.2 | -0.4 | 0.7 | -0.3 | 0.5 | 0.6 | |
| 23 | 22 | 19 | 27 | 27 | 22 | 18 | 19 | 15 | 16 | 13 | 11 | 54 | |
| 19 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 9.5 | -29 | -21 | 8.0 | 13 | -21 | 1.4 | -15 | -1.9 | -3.5 | -2.8 | 12 | 3.7 | |
| 1.5 | 0.6 | 0.1 | 1.8 | 0.0 | 0.2 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 51 | 71 | 60 | 11 | 46 | -126 | 29 | 42 | 75 | 40 | 35 | 33 | 183 | |
| – | – | – | – | – | 1.1 | – | – | 0.7 | – | 0.4 | – | – | |
| 2.1 | 9.5 | 22 | 49 | 1.5 | 219 | 0.8 | 0.0 | 0.7 | 0.0 | 0.9 | 139 | 140 | |
| -15 | 5.4 | -7.6 | 9.1 | -19 | 18 | -28 | -31 | 21 | -22 | -8.5 | 121 | 110 | |
| -70 | -76 | -89 | -52 | -66 | -75 | -58 | -74 | -55 | -62 | -45 | -51 | -213 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.